Evidence map›Paper›PMID 30042363›Full record

ArticleJournal of personalized medicine2018

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.

Aniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, Amanda R Elsey, Toni I Pollin, Andrea H Ramirez, Kristin W Weitzel, Carol R Horowitz

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03713333 (Implementation of High Definition Screening Using Handheld Imaging and Digital Health Technologies Within a Learning Health System to Identify Cardiovascular Disease at the Point-of-care), which is not on this map. Cited by 75 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 2 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03713333 nacompletednot on this map

Implementation of High Definition Screening Using Handheld Imaging and Digital Health Technologies Within a Learning Health System to Identify Cardiovascular Disease at the Point-of-care: The ASE-INNOVATE Program

TypeinterventionalSponsorScripps HealthRan2018 to 2020Enrolled374ConditionsCardiovascular Diseases, Hypertension, Heart Failure, Atrial FibrillationArmsDigital Health Device Diagnostics
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 2 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Primary care provider practices, attitudes, and confidence with hereditary cancer risk assessment and testing: A mixed methods study.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Attitudes, knowledge, and risk perceptions of patients who received elective genomic testing as a clinical service.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Aniwaa Owusu ObengThe Charles Bronfman Institute for Personalized Medicine and Department of Genetics and Genomic Sciences, The Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. aniwaa.owusu-obeng@mssm.edu.
Kezhen FeiCenter for Health Equity and Community-Engaged Research, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. kezhen.fei@mountsinai.org.
Kenneth D LevyDivision of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, 950 W. Walnut Street, Indianapolis, IN 46202, USA. kdlevy@iu.edu.ORCID 0000-0003-4043-7306
Amanda R ElseyDepartment of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL 32640, USA. aelsey@cop.ufl.edu.
Toni I PollinProgram for Personalized and Genomic Medicine, Departments of Medicine and Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA. tpollin@som.umaryland.edu.
Andrea H RamirezDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. andrea.h.ramirez@vanderbilt.edu.ORCID 0000-0002-6460-0182
Kristin W WeitzelDepartment of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL 32640, USA. kweitzel@cop.ufl.edu.
Carol R HorowitzCenter for Health Equity and Community-Engaged Research, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. carol.horowitz@mountsinai.org.
Icahn School of Medicine at Mount Sinai · USUniversity of Florida · USIndiana University School of MedicineMount Sinai Hospital · USUniversity of Maryland, Baltimore · USVanderbilt University · US

Funding

Using social networks to map and evaluate team science across CTSA hubsUL1TR001427 · NCATS · UNIVERSITY OF FLORIDA · PI MITCHELL, DUANE A. · 2015 to 2024
$37.2M
MSHS Translational Science HubUL1TR001433 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WRIGHT, ROSALIND J · 2015 to 2019
$26.6M
NCATS NIH HHS UL1 TR001427NCATS NIH HHS UL1 TR001433
6 · The paper itself

Abstract

Genetic medicine is one of the key components of personalized medicine, but adoption in clinical practice is still limited. To understand potential barriers and provider attitudes, we surveyed 285 physicians from five Implementing GeNomics In pracTicE (IGNITE) sites about their perceptions as to the clinical utility of genetic data as well as their preparedness to integrate it into practice. These responses were also analyzed in comparison to the type of study occurring at the physicians' institution (pharmacogenetics versus disease genetics). The majority believed that genetic testing is clinically useful; however, only a third believed that they had obtained adequate training to care for genetically "high-risk" patients. Physicians involved in pharmacogenetics initiatives were more favorable towards genetic testing applications; they found it to be clinically useful and felt more prepared and confident in their abilities to adopt it into their practice in comparison to those participating in disease genetics initiatives. These results suggest that investigators should explore which attributes of clinical pharmacogenetics (such as the use of simplified genetics-guided recommendations) can be implemented to improve attitudes and preparedness to implement disease genetics in care. Most physicians felt unprepared to use genetic information in their practice; accordingly, major steps should be taken to develop effective clinical tools and training strategies for physicians.

Indexed as

barrierschronic diseaseclinical implementationclinical utilitygenetic medicinegenetic testingpharmacogeneticsphysician attitudesphysician education

Identifiers

PMID30042363
PMCPMC6163471
OpenAlexW2884510764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.